Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-08 Sale | 2024-03-11 8:09 pm | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 2,092 | $45.69 | $95,583 | 16,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-12 Option Award | 2024-06-12 4:46 pm | N/A N/A | Alector Inc. | ALEC | GAROFALO ELIZABETH A. Director | 35,000 | $0 | 61,250 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:42 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 6:00 pm | N/A 2034-05-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 25,346 | $0 | 47,860 (Direct) | View |
| 2024-05-29 Exercise | 2024-05-31 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 6,652 | $0 | 47,860 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:09 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 3,500 | $18.56 | 16,500 (Direct) | View |
| 2024-03-08 Tax Withholding | 2024-03-11 8:09 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 1,408 | $46.16 | 16,500 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-11 8:09 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 3,500 | $0 | 16,500 (Direct) | View |
| 2023-12-05 Gift | 2023-12-06 6:30 pm | N/A N/A | Alector Inc. | ALEC | GAROFALO ELIZABETH A. Director | 9,459 | $0 | 26,250 (Direct) | View |
| 2023-11-24 Gift | 2023-11-28 5:32 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 2,918 | $0 | 15,862 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:01 pm | N/A 2033-06-14 | Alector Inc. | ALEC | GAROFALO ELIZABETH A. Director | 38,610 | $0 | 48,069 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 9:34 pm | N/A 2033-05-31 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 17,697 | $0 | 36,477 (Direct) | View |
| 2022-06-07 Exercise | 2023-06-05 9:34 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 16,862 | $0 | 36,477 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-02 5:22 pm | N/A 2033-06-01 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 18,475 | $0 | 18,475 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:31 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 7:18 pm | N/A 2032-06-16 | Alector Inc. | ALEC | GAROFALO ELIZABETH A. Director | 28,377 | $0 | 28,377 (Direct) | View |
| 2022-06-13 Option Award | 2022-06-15 4:21 pm | N/A 2032-06-12 | EXICURE INC. | XCUR | GAROFALO ELIZABETH A. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 8:34 pm | N/A 2032-06-06 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 22,920 | $0 | 22,920 (Direct) | View |
| 2021-09-29 Exercise | 2021-10-01 5:33 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 1,918 | $0 | 3,837 (Direct) | View |
| 2021-09-23 Option Award | 2021-09-27 8:00 pm | N/A 2031-09-23 | Alector Inc. | ALEC | GAROFALO ELIZABETH A. Director | 33,235 | $0 | 33,235 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-24 4:41 pm | N/A 2031-06-21 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 18,028 | $0 | 18,028 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 5:14 pm | N/A 2031-06-01 | EXICURE INC. | XCUR | GAROFALO ELIZABETH A. Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:00 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 20,000 | $0 | 20,000 (Direct) | View |
Ownership | 2021-06-03 8:57 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | GAROFALO ELIZABETH A. Director | 0 | $0 | 0 (Direct) | View |
| 2021-03-05 Option Award | 2021-03-08 6:57 pm | N/A 2031-03-04 | EXICURE INC. | XCUR | GAROFALO ELIZABETH A. Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-09-29 Option Award | 2020-10-01 5:04 pm | N/A 2030-09-28 | ACADIA PHARMACEUTICALS INC | ACAD | GAROFALO ELIZABETH A. Director | 10,702 | $0 | 10,702 (Direct) | View |